Duality Advisers, LP Madrigal Pharmaceuticals, Inc. Put Options Transaction History
Duality Advisers, LP
- $0
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MDGL
# of Institutions
371Shares Held
23.2MCall Options Held
738KPut Options Held
473K-
Janus Henderson Group PLC London, X02.19MShares$1.07 Billion0.34% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.09MShares$1.02 Billion32.86% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$975 Million9.27% of portfolio
-
Baker Bros. Advisors LP New York, NY1.98MShares$967 Million6.06% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.88MShares$917 Million10.35% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $8.37B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...